554 related articles for article (PubMed ID: 20595680)
1. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.
Meng XM; Huang XR; Chung AC; Qin W; Shao X; Igarashi P; Ju W; Bottinger EP; Lan HY
J Am Soc Nephrol; 2010 Sep; 21(9):1477-87. PubMed ID: 20595680
[TBL] [Abstract][Full Text] [Related]
2. Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis.
Zhang L; Liu C; Meng XM; Huang C; Xu F; Li J
Mol Cell Biochem; 2015 Feb; 400(1-2):17-28. PubMed ID: 25351340
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS5 protects against TGF-β-induced renal fibrosis via the Smad3/miRNA-142-5p axis.
Zhang YY; Tan RZ; Yu Y; Niu YY; Yu C
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F517-F526. PubMed ID: 34486400
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
[TBL] [Abstract][Full Text] [Related]
7. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
8. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ
J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746
[TBL] [Abstract][Full Text] [Related]
10. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
11. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
13. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.
Inazaki K; Kanamaru Y; Kojima Y; Sueyoshi N; Okumura K; Kaneko K; Yamashiro Y; Ogawa H; Nakao A
Kidney Int; 2004 Aug; 66(2):597-604. PubMed ID: 15253712
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA
Wang P; Luo ML; Song E; Zhou Z; Ma T; Wang J; Jia N; Wang G; Nie S; Liu Y; Hou F
Sci Transl Med; 2018 Oct; 10(462):. PubMed ID: 30305452
[TBL] [Abstract][Full Text] [Related]
15. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.
Chung AC; Huang XR; Meng X; Lan HY
J Am Soc Nephrol; 2010 Aug; 21(8):1317-25. PubMed ID: 20488955
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
[TBL] [Abstract][Full Text] [Related]
17. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.
Poncelet AC; Schnaper HW; Tan R; Liu Y; Runyan CE
J Biol Chem; 2007 May; 282(21):15534-40. PubMed ID: 17400544
[TBL] [Abstract][Full Text] [Related]
18. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.
Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF
J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
20. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
